Cardiac mitochondrial dysfunction during hyperglycemia - The role of oxidative stress and p66Shc signaling

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 1, 2013, Pages 114-122

  Diogo, Catia V ^a,b   Suski, Jan M ^b,d   Lebiedzinska, Magdalena ^b   Karkucinska Wieckowska, Agnieszka ^c   Wojtala, Aleksandra ^b   Pronicki, MacIej ^c   Duszynski, Jerzy ^b   Pinton, Paolo ^d   Portincasa, Piero ^e   Oliveira, Paulo J ^a   Wieckowski, Mariusz R ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Hyperglycemia; Mitochondrial dysfunction; p66Shc; ROS

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HEXOSAMINE; P66SHC PROTEIN; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; REVIEW;

EID: 84870696911     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.07.004     Document Type: Article

References (145)

1. R.D. Abbott, R.P. Donahue, W.B. Kannel, and P.W. Wilson The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study JAMA 260 1988 3456 3460
2. N. Ahmed Advanced glycation endproducts - role in pathology of diabetic complications Diabetes Research and Clinical Practice 67 2005 3 21
3. T. Almdal, H. Scharling, J.S. Jensen, and H. Vestergaard The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up Archives of Internal Medicine 164 2004 1422 1426
4. D.V. Anand, E. Lim, A. Lahiri, and J.J. Bax The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects European Heart Journal 27 2006 905 912
5. I. Arany, A. Faisal, J.S. Clark, T. Vera, R. Baliga, and Y. Nagamine p66Shc-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury American Journal of Physiology. Renal Physiology 298 2010 F1214 F1221
6. J.S. Armstrong Mitochondria-directed therapeutics Antioxidants and Redox Signalling 10 2008 575 578
7. D.S. Bell Heart failure: the frequent, forgotten, and often fatal complication of diabetes Diabetes Care 26 2003 2433 2441
8. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
9. M. Brownlee, and A. Cerami The biochemistry of the complications of diabetes mellitus Annual Review of Biochemistry 50 1981 385 432
10. J. Buchanan, P.K. Mazumder, P. Hu, G. Chakrabarti, M.W. Roberts, and U.J. Yun Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity Endocrinology 146 2005 5341 5349
11. W. Cai, J.C. He, L. Zhu, X. Chen, G.E. Striker, and H. Vlassara AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation American Journal of Physiology. Cell Physiology 294 2008 C145 C152
12. G.G. Camici, M. Schiavoni, P. Francia, M. Bachschmid, I. Martin-Padura, and M. Hersberger Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress Proceedings of the National Academy of Sciences of the United States of America 104 2007 5217 5222
13. A.N. Carley, and D.L. Severson Fatty acid metabolism is enhanced in type 2 diabetic hearts Biochimica et Biophysica Acta 1734 2005 112 126
14. A. Carpi, R. Menabo, N. Kaludercic, P. Pelicci, F. Di Lisa, and M. Giorgio The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury Biochimica et Biophysica Acta 1787 2009 774 780
15. J. Chintapalli, S. Yang, D. Opawumi, S.R. Goyal, N. Shamsuddin, and A. Malhotra Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype American Journal of Physiology. Renal Physiology 292 2007 F523 F530
16. A. Cohen-Solal, F. Beauvais, and D. Logeart Heart failure and diabetes mellitus: epidemiology and management of an alarming association Journal of Cardiac Failure 14 2008 615 625
17. M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, and K.C. Sourris RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes Journal of the American Society of Nephrology 20 2009 742 752
18. M. Coutinho, H.C. Gerstein, Y. Wang, and S. Yusuf The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240
19. P.A. Craven, C.M. Davidson, and F.R. DeRubertis Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids Diabetes 39 1990 667 674
20. G. Davi, G. Ciabattoni, A. Consoli, A. Mezzetti, A. Falco, and S. Santarone In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation Circulation 99 1999 224 229
21. M.F. Di Carli, D. Bianco-Batlles, M.E. Landa, A. Kazmers, H. Groehn, and O. Muzik Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus Circulation 100 1999 813 819
22. M. Diamant, H.J. Lamb, Y. Groeneveld, E.L. Endert, J.W. Smit, and J.J. Bax Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus Journal of the American College of Cardiology 42 2003 328 335
23. W. Droge Free radicals in the physiological control of cell function Physiological Reviews 82 2002 47 95
24. X.L. Du, D. Edelstein, L. Rossetti, I.G. Fantus, H. Goldberg, and F. Ziyadeh Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation Proceedings of the National Academy of Sciences of the United States of America 97 2000 12222 12226
25. J.G. Duncan Mitochondrial dysfunction in diabetic cardiomyopathy Biochimica et Biophysica Acta 1813 2011 1351 1359
26. E.P. Feener, P. Xia, T. Inoguchi, T. Shiba, M. Kunisaki, and G.L. King Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression Contributions to Nephrology 118 1996 180 187
27. B.N. Finck, and D.P. Kelly Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart Journal of Molecular and Cellular Cardiology 34 2002 1249 1257
28. C.E. Flarsheim, I.L. Grupp, and M.A. Matlib Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart American Journal of Physiology 271 1996 H192 H202
29. K. Foley, S. Boguslavsky, and A. Klip Endocytosis, recycling, and regulated exocytosis of glucose transporter 4 Biochemistry 50 2011 3048 3061
30. F. Folli, D. Corradi, P. Fanti, A. Davalli, A. Paez, and A. Giaccari The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach Current Diabetes Reviews 7 2011 313 324
31. E.S. Ford, G. Zhao, and C. Li Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence Journal of the American Medical Association 55 2010 1310 1317
32. C.S. Fox, S. Coady, P.D. Sorlie, D. Levy, J.B. Meigs, and R.B. D'Agostino Sr. Trends in cardiovascular complications of diabetes JAMA 292 2004 2495 2499
33. I. Gabriely, X.M. Yang, J.A. Cases, X.H. Ma, L. Rossetti, and N. Barzilai Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway Atherosclerosis 160 2002 115 122
34. F. Garcia Soriano, L. Virag, P. Jagtap, E. Szabo, J.G. Mabley, and L. Liaudet Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation Nature Medicine 7 2001 108 113
35. H.C. Gerstein, P. Pais, J. Pogue, and S. Yusuf Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study Journal of the American Medical Association 33 1999 612 619
36. H.C. Gerstein, J.F. Mann, Q. Yi, B. Zinman, S.F. Dinneen, and B. Hoogwerf Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426
37. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circulation Research 107 2010 1058 1070
38. H.J. Goldberg, C.I. Whiteside, and I.G. Fantus The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta Journal of Biological Chemistry 277 2002 33833 33841
39. C.B. Granger, R.M. Califf, S. Young, R. Candela, J. Samaha, and S. Worley Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group Journal of the American College of Cardiology 21 1993 920 925
40. S.M. Grundy Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute Arteriosclerosis, Thrombosis, and Vascular Biology 25 2005 2243 2244
41. S.M. Grundy, I.J. Benjamin, G.L. Burke, A. Chait, R.H. Eckel, and B.V. Howard Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 100 1999 1134 1146
42. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction New England Journal of Medicine 339 1998 229 234
43. S. Haga, K. Terui, H.Q. Zhang, S. Enosawa, W. Ogawa, and H. Inoue Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms Journal of Clinical Investigation 112 2003 989 998
44. E.K. Hoogeveen, P.J. Kostense, C. Jakobs, J.M. Dekker, G. Nijpels, and R.J. Heine Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study Circulation 101 2000 1506 1511
45. J.V. Hunt, M.A. Bottoms, and M.J. Mitchinson Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production Biochemical Journal 291 Pt 2 1993 529 535
46. T. Inoguchi, R. Battan, E. Handler, J.R. Sportsman, W. Heath, and G.L. King Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation Proceedings of the National Academy of Sciences of the United States of America 89 1992 11059 11063
47. H. Ishii, M.R. Jirousek, D. Koya, C. Takagi, P. Xia, and A. Clermont Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor Science 272 1996 728 731
48. L.R. James, D. Tang, A. Ingram, H. Ly, K. Thai, and L. Cai Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation Diabetes 51 2002 1146 1156
49. W.B. Kannel Lipids, diabetes, and coronary heart disease: insights from the Framingham Study American Heart Journal 110 1985 1100 1107
50. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular risk factors: the Framingham study Circulation 59 1979 8 13
51. D.E. Kelley, J. He, E.V. Menshikova, and V.B. Ritov Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2002 2944 2950
52. R.J. Keogh, M.E. Dunlop, and R.G. Larkins Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation Metabolism: Clinical and Experimental 46 1997 41 47
53. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431
54. D. Koya, and G.L. King Protein kinase C activation and the development of diabetic complications Diabetes 47 1998 859 866
55. A.S. Krolewski, E.J. Kosinski, J.H. Warram, O.S. Leland, E.J. Busick, and A.C. Asmal Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus American Journal of Cardiology 59 1987 750 755
56. J. Kuusisto, L. Mykkanen, K. Pyorala, and M. Laakso NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 43 1994 960 967
57. H.C. Kwaan Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes Diabetes 41 Suppl. 2 1992 32 35
58. E.W. Lam, R.E. Francis, and M. Petkovic FOXO transcription factors: key regulators of cell fate Biochemical Society Transactions 34 2006 722 726
59. A. Langer, M.R. Freeman, R.G. Josse, and P.W. Armstrong Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia Journal of the American College of Cardiology 25 1995 610 618
60. O. Lashin, and A. Romani Hyperglycemia does not alter state 3 respiration in cardiac mitochondria from type-I diabetic rats Molecular and Cellular Biochemistry 267 2004 31 37
61. M. Lebiedzinska, J. Duszynski, R. Rizzuto, P. Pinton, and M.R. Wieckowski Age-related changes in levels of p66Shc and serine 36-phosphorylated p66Shc in organs and mouse tissues Archives of Biochemistry and Biophysics 486 2009 73 80
62. M. Lebiedzinska, A. Karkucinska-Wieckowska, C. Giorgi, E. Karczmarewicz, E. Pronicka, and P. Pinton Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders Biochimica et Biophysica Acta 1797 2010 952 960
63. L. Li, and G. Renier Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression Metabolism: Clinical and Experimental 55 2006 1516 1523
64. M. Li, K.R. Chiou, and D.A. Kass Shear stress inhibition of H(2)O(2) induced p66(Shc) phosphorylation by ASK1-JNK inactivation in endothelium Heart and Vessels 22 2007 423 427
65. M. Liscovitch, and L.C. Cantley Lipid second messengers Cell 77 1994 329 334
66. G.D. Lopaschuk, J.R. Ussher, C.D. Folmes, J.S. Jaswal, and W.C. Stanley Myocardial fatty acid metabolism in health and disease Physiological Reviews 90 2010 207 258
67. J. Lumini-Oliveira, J. Magalhaes, C.V. Pereira, A.C. Moreira, P.J. Oliveira, and A. Ascensao Endurance training reverts heart mitochondrial dysfunction, permeability transition and apoptotic signaling in long-term severe hyperglycemia Mitochondrion 11 2011 54 63
68. T.F. Luscher, M.A. Creager, J.A. Beckman, and F. Cosentino Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II Circulation 108 2003 1655 1661
69. A. Malhotra, H. Vashistha, V.S. Yadav, M.G. Dube, S.P. Kalra, and M. Abdellatif Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis American Journal of Physiology. Heart and Circulatory Physiology 296 2009 H380 H388
70. J.R. Margolis, W.S. Kannel, M. Feinleib, T.R. Dawber, and P.M. McNamara Clinical features of unrecognized myocardial infarction - silent and symptomatic. Eighteen year follow-up: the Framingham study American Journal of Cardiology 32 1973 1 7
71. J. Marin-Garcia, and M.J. Goldenthal Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis Cardiovascular Research 54 2002 516 527
72. P.K. Mazumder, B.T. O'Neill, M.W. Roberts, J. Buchanan, U.J. Yun, and R.C. Cooksey Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts Diabetes 53 2004 2366 2374
73. D.A. McClain, and E.D. Crook Hexosamines and insulin resistance Diabetes 45 1996 1003 1009
74. S. Menini, C. Iacobini, C. Ricci, G. Oddi, C. Pesce, and F. Pugliese Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation Diabetologia 50 2007 1997 2007
75. E. Messina, and A. Giacomello Diabetic cardiomyopathy: a cardiac stem cell disease involving p66Shc, an attractive novel molecular target for heart failure therapy Circulation Research 99 2006 1 2
76. E. Migliaccio, M. Giorgio, S. Mele, G. Pelicci, P. Reboldi, and P.P. Pandolfi The p66shc adaptor protein controls oxidative stress response and life span in mammals Nature 402 1999 309 313
77. V.K. Mootha, C.M. Lindgren, K.F. Eriksson, A. Subramanian, S. Sihag, and J. Lehar PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nature Genetics 34 2003 267 273
78. P.R. Moreno, A.M. Murcia, I.F. Palacios, M.N. Leon, V.H. Bernardi, and V. Fuster Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus Circulation 102 2000 2180 2184
79. K. Morino, K.F. Petersen, S. Dufour, D. Befroy, J. Frattini, and N. Shatzkes Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents Journal of Clinical Investigation 115 2005 3587 3593
80. V.K. Murthy, and J.C. Shipp Accumulation of myocardial triglycerides ketotic diabetes; evidence for increased biosynthesis Diabetes 26 1977 222 229
81. A. Natalicchio, F. De Stefano, S. Perrini, L. Laviola, A. Cignarelli, and C. Caccioppoli Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts American Journal of Physiology. Endocrinology and Metabolism 296 2009 E228 E237
82. S. Nemoto, C.A. Combs, S. French, B.H. Ahn, M.M. Fergusson, and R.S. Balaban The mammalian longevity-associated gene product p66shc regulates mitochondrial metabolism Journal of Biological Chemistry 281 2006 10555 10560
83. E. Niakan, Y. Harati, L.A. Rolak, J.P. Comstock, and R. Rokey Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy Archives of Internal Medicine 146 1986 2229 2230
84. D.M. Niedowicz, and D.L. Daleke The role of oxidative stress in diabetic complications Cell Biochemistry and Biophysics 43 2005 289 330
85. T. Nishikawa, D. Edelstein, and M. Brownlee The missing link: a single unifying mechanism for diabetic complications Kidney International. Supplement 77 2000 S26 S30
86. Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C Science 258 1992 607 614
87. Y. Nishizuka Protein kinase C and lipid signaling for sustained cellular responses FASEB Journal 9 1995 484 496
88. A. Norhammar, A. Tenerz, G. Nilsson, A. Hamsten, S. Efendic, and L. Ryden Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2002 2140 2144
89. P.J. Oliveira, A.P. Rolo, R. Seica, C.M. Palmeira, M.S. Santos, and A.J. Moreno Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate Bioscience Reports 21 2001 45 53
90. P.J. Oliveira, R. Seica, P.M. Coxito, A.P. Rolo, C.M. Palmeira, and M.S. Santos Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats FEBS Letters 554 2003 511 514
91. P.J. Oliveira, R. Seica, D.L. Santos, A.P. Rolo, V.A. Sardao, and F.M. Ferreira Vitamin E or coenzyme Q10 administration is not fully advantageous for heart mitochondrial function in diabetic goto kakizaki rats Mitochondrion 3 2004 337 345
92. M. Ozaki, S. Suzuki, and K. Irani Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase FASEB Journal 16 2002 889 890
93. M. Ozaki, S. Haga, H.Q. Zhang, K. Irani, and S. Suzuki Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1 Cell Death and Differentiation 10 2003 508 515
94. E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calo, and A. Avogaro Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress Journal of Clinical Endocrinology and Metabolism 90 2005 1130 1136
95. G. Palasciano, A. Moschetta, V.O. Palmieri, I. Grattagliano, G. Iacobellis, and P. Portincasa Non-alcoholic fatty liver disease in the metabolic syndrome Current Pharmaceutical Design 13 2007 2193 2198
96. G. Pani, O.R. Koch, and T. Galeotti The p53-p66shc-manganese superoxide dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species International Journal of Biochemistry and Cell Biology 41 2009 1002 1005
97. M.E. Patti, A.J. Butte, S. Crunkhorn, K. Cusi, R. Berria, and S. Kashyap Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 Proceedings of the National Academy of Sciences of the United States of America 100 2003 8466 8471
98. M. Pellegrini, S. Pacini, and C.T. Baldari p66SHC: the apoptotic side of Shc proteins Apoptosis 10 2005 13 18
99. M. Petruzzelli, G. Lo Sasso, P. Portincasa, G. Palasciano, and A. Moschetta Targeting the liver in the metabolic syndrome: evidence from animal models Current Pharmaceutical Design 13 2007 2199 2207
100. G.M. Pieper, and H. Riaz ul Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C Journal of Cardiovascular Pharmacology 30 1997 528 532
101. P. Pinton, A. Rimessi, S. Marchi, F. Orsini, E. Migliaccio, and M. Giorgio Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc Science 315 2007 659 663
102. D. Portilla, G. Dai, J.M. Peters, F.J. Gonzalez, M.D. Crew, and A.D. Proia Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure American Journal of Physiology. Renal Physiology 278 2000 F667 F675
103. S. Purdom, and Q.M. Chen Linking oxidative stress and genetics of aging with p66Shc signaling and forkhead transcription factors Biogerontology 4 2003 181 191
104. Q. Qiao, K. Pyorala, M. Pyorala, A. Nissinen, J. Lindstrom, and R. Tilvis Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose European Heart Journal 23 2002 1267 1275
105. S. Raha, and B.H. Robinson Mitochondria, oxygen free radicals, disease and ageing Trends in Biochemical Sciences 25 2000 502 508
106. K. Ranjadayalan, V. Umachandran, G. Ambepityia, P.G. Kopelman, P.G. Mills, and A.D. Timmis Prolonged anginal perceptual threshold in diabetes: effects on exercise capacity and myocardial ischemia Journal of the American College of Cardiology 16 1990 1120 1124
107. G.M. Reaven Banting Lecture 1988. Role of insulin resistance in human disease Nutrition 13 1997 65 [discussion 64, 66]
108. H.E. Resnick, and B.V. Howard Diabetes and cardiovascular disease Annual Review of Medicine 53 2002 245 267
109. A.E. Reszko, T. Kasumov, F. David, K.A. Jobbins, K.R. Thomas, and C.L. Hoppel Peroxisomal fatty acid oxidation is a substantial source of the acetyl moiety of malonyl-CoA in rat heart Journal of Biological Chemistry 279 2004 19574 19579
110. V.B. Ritov, E.V. Menshikova, J. He, R.E. Ferrell, B.H. Goodpaster, and D.E. Kelley Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes Diabetes 54 2005 8 14
111. B. Rodrigues, M.C. Cam, and J.H. McNeill Myocardial substrate metabolism: implications for diabetic cardiomyopathy Journal of Molecular and Cellular Cardiology 27 1995 169 179
112. A.P. Rolo, and C.M. Palmeira Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress Toxicology and Applied Pharmacology 212 2006 167 178
113. M. Rota, N. LeCapitaine, T. Hosoda, A. Boni, A. De Angelis, and M.E. Padin-Iruegas Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene Circulation Research 99 2006 42 52
114. D.L. Santos, C.M. Palmeira, R. Seica, J. Dias, J. Mesquita, and A.J. Moreno Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat Molecular and Cellular Biochemistry 246 2003 163 170
115. N. Sarwar, P. Gao, S.R. Seshasai, R. Gobin, S. Kaptoge, and E. Di Angelantonio Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2010 2215 2222
116. E. Schleicher, and U. Friess Oxidative stress, AGE, and atherosclerosis Kidney International. Supplement 2007 S17 S26
117. R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus Journal of the American College of Cardiology 47 2006 65 71
118. S. Sharma, J.V. Adrogue, L. Golfman, I. Uray, J. Lemm, and K. Youker Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart FASEB Journal 18 2004 1692 1700
119. X. Shen, S. Zheng, V. Thongboonkerd, M. Xu, W.M. Pierce Jr., and J.B. Klein Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes American Journal of Physiology. Endocrinology and Metabolism 287 2004 E896 E905
120. T. Shiba, T. Inoguchi, J.R. Sportsman, W.F. Heath, S. Bursell, and G.L. King Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation American Journal of Physiology 265 1993 E783 E793
121. D.E. Singer, D.M. Nathan, K.M. Anderson, P.W. Wilson, and J.C. Evans Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study Diabetes 41 1992 202 208
122. V.P. Skulachev, Y.N. Antonenko, D.A. Cherepanov, B.V. Chernyak, D.S. Izyumov, and L.S. Khailova Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs) Biochimica et Biophysica Acta 1797 2010 878 889
123. Y. Song, Y. Du, S.D. Prabhu, and P.N. Epstein Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and in vitro contractility The Review of Diabetic Studies 4 2007 159 168
124. J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
125. W.C. Stanley, G.D. Lopaschuk, and J.G. McCormack Regulation of energy substrate metabolism in the diabetic heart Cardiovascular Research 34 1997 25 33
126. J. Suski, M. Lebiedzinska, N.G. Machado, P.J. Oliveira, P. Pinton, and J. Duszynski Mitochondrial tolerance to drugs and toxic agents in ageing and disease Current Drug Targets 12 2011 827 849
127. L.S. Szczepaniak, R.G. Victor, L. Orci, and R.H. Unger Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America Circulation Research 101 2007 759 767
128. K. Terui, S. Haga, S. Enosawa, N. Ohnuma, and M. Ozaki Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction Biochemical Journal 380 2004 203 209
129. K. Terui, S. Enosawa, S. Haga, H.Q. Zhang, H. Kuroda, and K. Kouchi Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD Journal of Hepatology 41 2004 957 965
130. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
131. I.V. Turko, L. Li, K.S. Aulak, D.J. Stuehr, J.Y. Chang, and F. Murad Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes Journal of Biological Chemistry 278 2003 33972 33977
132. J.F. Turrens Mitochondrial formation of reactive oxygen species The Journal of Physiology 552 2003 335 344
133. P. Ulrich, and A. Cerami Protein glycation, diabetes, and aging Recent Progress in Hormone Research 56 2001 1 21
134. O. Vaccaro, L.E. Eberly, J.D. Neaton, L. Yang, G. Riccardi, and J. Stamler Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial Archives of Internal Medicine 164 2004 1438 1443
135. K. Wachtell, H. Ibsen, M.H. Olsen, K. Borch-Johnsen, L.H. Lindholm, and C.E. Mogensen Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study Annals of Internal Medicine 139 2003 901 906
136. D.C. Wallace Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256 1992 628 632
137. J.R. Williamson, K. Chang, M. Frangos, K.S. Hasan, Y. Ido, and T. Kawamura Hyperglycemic pseudohypoxia and diabetic complications Diabetes 42 1993 801 813
138. S.P. Wolff, and R.T. Dean Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes Biochemical Journal 245 1987 243 250
139. P. Xia, R.M. Kramer, and G.L. King Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2 Journal of Clinical Investigation 96 1995 733 740
140. Y.M. Yannoni, M. Gaestel, and L.L. Lin P66(ShcA) interacts with MAPKAP kinase 2 and regulates its activity FEBS Letters 564 2004 205 211
141. K.K. Yerneni, W. Bai, B.V. Khan, R.M. Medford, and R. Natarajan Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells Diabetes 48 1999 855 864
142. I. Yokoyama, S. Momomura, T. Ohtake, K. Yonekura, J. Nishikawa, and Y. Sasaki Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus Journal of the American College of Cardiology 30 1997 1472 1477
143. S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avezum, and F. Lanas Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
144. G. Zaccagnini, F. Martelli, P. Fasanaro, A. Magenta, C. Gaetano, and A. Di Carlo p66ShcA modulates tissue response to hindlimb ischemia Circulation 109 2004 2917 2923
145. P. Zimmet, K.G. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787